PAM
FBIO icon

PVG Asset Management’s Fortress Biotech FBIO Stock Holding History

PVG Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,788
Closed -$142K – 132
2025
Q4 		$142K Sell
38,788
-34,353
-47% -$97.9K 0.3% 82
2025
Q3 		$270K Sell
73,141
-248,820
-77% -$629K 0.99% 39
2025
Q2 		$599K Sell
321,961
-150,260
-32% -$260K 2.04% 14
2025
Q1 		$737K Buy
472,221
+85,926
+22% +$151K 3.21% 8
2024
Q4 		$782K Buy
386,295
+12,505
+3% +$22.7K 3.7% 7
2024
Q3 		$540K Buy
373,790
+218,115
+140% +$415K 2.17% 11
2024
Q2 		$266K Buy
+155,675
New +$282K 1.05% 24
2023
Q4 		$396K Buy
+131,490
New +$348K 1.91% 10
2022
Q4 		– Sell
-6,367
Closed -$82.1K – 43
2022
Q3 		$82.1K Buy
+6,367
New +$95.3K 0.32% 27
2021
Q4 		$248K Buy
+6,610
New +$295K 0.91% 28
2019
Q4 		– Sell
-5,277
Closed -$112K – 70
2019
Q3 		$112K Buy
+5,277
New +$124K 0.12% 75

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

PVG Asset Management's FBIO Position: Q1 2026 in Review

PVG Asset Management sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 38,788 shares — an estimated $142K sold.

PVG Asset Management first reported a position in FBIO in Q3 2019 and held it in 11 quarters. The position peaked at $782K in Q4 2024. 52 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • PVG Asset Management reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • PVG Asset Management sold 38,788 Fortress Biotech shares in Q1 2026, an estimated $142K.
  • PVG Asset Management first reported a position in Fortress Biotech in Q3 2019 and held it in 11 quarters.
  • PVG Asset Management's Fortress Biotech position peaked at $782K in Q4 2024.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on PVG Asset Management's 13F filing for Q1 2026, filed 16 Jun 2026.